StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) stock

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$292.82−1.73 (-0.59%)

Close on Nov 17, 2026Market cap $517.45BP/E 82.7Yield 2.27%

AbbVie pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

AbbVie's pe ratio was 83.3× on Nov 11, 2026, against 172.5× a year earlier. Over the last 5 years it ranged from 19.0× to 173.1×, with a median of 61.7×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202683.3×−89.8
2025Dec 31, 2025173.1×+111.4
2024Dec 31, 202461.7×+19.2
2023Dec 29, 202342.5×+20.9
2022Dec 30, 202221.6×−10.7
2021Dec 31, 202132.2×+9.6
2020Dec 31, 202022.7×−18.1
2019Dec 31, 201940.8×+21.8
2018Dec 31, 201819.0×−4.5
2017Dec 29, 201723.5×+6.6
2016Dec 30, 201616.9×−18.1
2015Dec 31, 201535.1×+6.6
2014Dec 31, 201428.5×+9.9
2013Dec 31, 201318.6×–

More AbbVie figures

See a number that looks wrong?